Legal & General Group Plc - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$119,000
-55.1%
127,185
+5.1%
0.00%
Q4 2019$265,000
-20.2%
121,023
+4.5%
0.00%
Q3 2019$332,000
-58.5%
115,813
+11.1%
0.00%
Q2 2019$800,000
-42.3%
104,2450.0%0.00%
-100.0%
Q1 2019$1,386,000
-5.6%
104,245
+9.4%
0.00%0.0%
Q4 2018$1,468,000
-21.4%
95,285
+0.5%
0.00%0.0%
Q3 2018$1,867,000
-35.8%
94,825
-7.6%
0.00%
-50.0%
Q2 2018$2,908,000
+26.8%
102,619
+5.9%
0.00%0.0%
Q1 2018$2,293,000
+13.4%
96,867
+2.9%
0.00%
+100.0%
Q4 2017$2,022,000
-4.7%
94,140
+4.9%
0.00%
-50.0%
Q3 2017$2,121,000
+21.3%
89,734
+1.1%
0.00%
+100.0%
Q2 2017$1,748,000
+1.2%
88,751
+9.3%
0.00%0.0%
Q1 2017$1,727,000
+14.9%
81,165
+1.4%
0.00%0.0%
Q4 2016$1,503,000
+65.7%
80,038
+84.0%
0.00%0.0%
Q3 2016$907,000
+213.8%
43,488
+280.9%
0.00%
Q2 2016$289,000
-4.9%
11,4160.0%0.00%
Q1 2016$304,000
-21.2%
11,416
+26.8%
0.00%
Q4 2015$386,000
+61.5%
9,0010.0%0.00%
Q3 2015$239,000
-14.0%
9,001
+9.5%
0.00%
Q2 2015$278,000
+0.7%
8,2170.0%0.00%
Q1 2015$276,000
+8.7%
8,217
+33.3%
0.00%
Q4 2014$254,000
+19.8%
6,1630.0%0.00%
Q3 2014$212,0006,1630.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,045,400$21,953,00012.28%
SCOPIA CAPITAL MANAGEMENT LP 5,568,306$116,934,0002.16%
GREAT POINT PARTNERS LLC 432,500$9,083,0001.80%
Consonance Capital Management LP 619,419$13,008,0001.36%
RA Capital Management 489,828$10,286,0001.26%
Ghost Tree Capital, LLC 300,000$6,300,0001.17%
DLD Asset Management, LP 281,900$5,920,0000.95%
DLD Asset Management, LP 281,900$5,914,0000.95%
Worth Venture Partners, LLC 36,650$770,0000.68%
Malaga Cove Capital, LLC 51,013$939,0000.57%
View complete list of ACORDA THERAPEUTICS INC shareholders